NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
August 1, 2006 • Volume 3 / Number 31 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
President Announces New NCAB Appointees

Director's Update
A New Platform for Cancer Research Advances

Spotlight
Helping Families Cope with Cancer

Cancer Research Highlights
Effectiveness of Antibiotics, Supplements Against Precancerous Gastric Lesions Varies

Combined Estrogen and Testosterone Use Increases Risk of Breast Cancer

Scientists Develop New Model for Estimating Melanoma Risk

Imatinib Linked to Cardiotoxicity

Annual Cancer Prevention Lecture Delivered

Featured Clinical Trial
Treatment for Malignant Ascites

Notes
John P. Hartinger Retires

Outcomes Assessment in Cancer Trials Conference Announced

Patient Navigator Training Program Held

Immunology Conference Slated for September

NCI Listens and Learns

Cancer Center Profile
Cold Spring Harbor Laboratory

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Cancer Center Profile Cancer Center Profile

Cold Spring Harbor Laboratory
Director: Dr. Bruce Stillman • One Bungtown Road, Cold Spring Harbor, NY 11724 • Phone: 516-367-8800 • Web site: http://www.cshl.edu

Cold Spring Harbor Laboratory Background
Cold Spring Harbor Laboratory is a private, nonprofit, basic research and educational institution that was founded in 1890. It was first intended by the Brooklyn Institute of Arts and Sciences for training high school and college teachers in marine biology, but has since expanded to the current research portfolio that includes activities in cancer biology, genomics and bioinformatics, neurobiology, and plant genetics.

Cold Spring Harbor Laboratory is recognized internationally for its scientific meetings and courses that attract more than 8,000 scientists to the campus each year. Its Watson School of Biological Sciences, named for former laboratory president and Nobel laureate Dr. James D. Watson, offers a Ph.D. program for a small group of exceptional students. The Laboratory also trains college undergraduates through the Undergraduate Research Program, high school students through the Partners for the Future Program, and grade-school children in its Nature Study summer camp.

The Cancer Center at Cold Spring Harbor Laboratory received its NCI designation in 1987 and focuses on the basic biology of human cancer. The Laboratory runs three major research programs: the Gene Expression Program, the Cell Biology Program, and the Cancer Genetics Program.

Research Activities
As a basic research Cancer Center, Cold Spring Harbor Laboratory research does not directly involve patients. The Cancer Center has close working relationships with clinical research centers that provide access to primary cancer samples for analysis in several studies.

Scientists at Cold Spring Harbor Laboratory study cell growth and the cancer cell cycle, gene silencing, apoptosis, chemotherapy, cellular senescence, microarrays, oncogenes and tumor suppressor genes, X-ray crystallography, protein-RNA interactions, RNA interference, signal transduction, SNPs, and the development of animal models to better represent human cancer, among other research topics.

Cold Spring Harbor Laboratory scientists are also studying computational genomics and developing databases and analytic tools to help manage the increasing information that has resulted from cancer research and new technology.

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health (NIH) is available at http://calendar.nih.gov.
Other Notable Programs
Researchers at Cold Spring Harbor Laboratory are using a new DNA microarray method that they developed, which is known as ROMA (representational oligonucleotide microarray analysis), to scan the human genome for cancer-causing mutations. ROMA has the potential to identify new genes involved in specific cancer types (useful for drug discovery) and to classify cancers in a new way that may provide better insights for diagnostics and therapy.

Other programs include an extensive animal models program to analyze and improve diagnostics and treatment, as well as the creation of an RNAi library for the entire human genome to uncover and validate new gene targets.

< Previous Section


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov